| Patents for C07K - Peptides (3,738) |
|---|
| 08/02/2011 | US7989605 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 08/02/2011 | CA2496538C Boronic ester and acid compounds, synthesis and uses |
| 07/26/2011 | CA2268331C Treatment of inner ear hair cells |
| 07/20/2011 | EP2345665A2 Flavivirus NS1 subunit vaccine |
| 07/20/2011 | EP1317279B1 Vaccine against streptococcus pneumoniae |
| 07/20/2011 | CN1951965B Glp-1衍生物 Glp-1 derivatives |
| 07/19/2011 | US7982015 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 07/19/2011 | US7981675 LITAF binding site peptides and methods of using the same |
| 07/19/2011 | CA2336445C Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 07/13/2011 | EP2343311A2 Peptide inhibitors of HK2 and their use |
| 07/13/2011 | EP2343086A2 Antibodies to CD40 |
| 07/13/2011 | EP1680442B1 Pif peptides biologic activities |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/07/2011 | US20110165185 Immunogenic peptides |
| 07/06/2011 | CN1871022B Peptides and compounds that bind to a receptor |
| 06/30/2011 | US20110158986 Humanized antibodies that sequester amyloid beta peptide |
| 06/30/2011 | US20110158981 Methods and Compositions for Inhibiting Binding of IgE to a High Affinity Receptor |
| 06/29/2011 | EP2338333A2 Glycopegylation methods and proteins/peptides produced by the methods |
| 06/29/2011 | CN101049502B Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/22/2011 | EP2336182A1 Treatment of TNF alpha related disorders |
| 06/22/2011 | EP2336168A1 Novel protein and method for producing the protein |
| 06/22/2011 | EP2336147A2 A beta immunogenic peptide carrier conjugates and methods of producing same |
| 06/16/2011 | US20110144008 Peptide agonists of glp-1 activity |
| 06/15/2011 | EP2333069A2 Therapeutic uses of IL-17 homologous polypeptides |
| 06/15/2011 | EP2332968A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332967A1 Stabilized alpha helical peptides derived from the BCL2-family for therapy. |
| 06/15/2011 | EP2332962A1 Cyclopenta[g]quinazoline compounds for use in the treatment of inflammatory or allergic conditions |
| 06/08/2011 | EP2330129A2 Anti-TNF antibodies, compositions, methods and uses |
| 05/31/2011 | US7951775 Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation |
| 05/25/2011 | EP2325317A1 Receptor nucleic acids and polypeptides |
| 05/25/2011 | EP2325303A2 Thermostable reverse transcriptases and uses thereof |
| 05/24/2011 | US7947272 Using mixture comprising inhibitors of CD4, CD25 and interleukin induction as tool in reducing immune response to tissue graft; preventing transplant rejection |
| 05/19/2011 | US20110117105 Method of treating immune disease using b-cell antibodies |
| 05/18/2011 | EP2322545A1 Analogues of GLP-1 |
| 05/11/2011 | EP2319524A1 Prostate stem cell antigen (PSCA) variants and subsequences thereof |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/10/2011 | US7939279 Mammalian T1R3 sweet taste receptors |
| 05/10/2011 | CA2415460C Widely applicable process for identifying modulators of g-protien-coupled receptors |
| 05/10/2011 | CA2292898C Bacterial pheromones and uses therefor |
| 04/27/2011 | EP2314313A1 Vaccine against streptococcus pneumoniae |
| 04/26/2011 | US7932060 Detecting and quantifies analytes by forming an analyte-specific amplicon through the interaction of single stranded DNA and antibody; high throughput assay |
| 04/26/2011 | US7931898 Methods and compositions for inhibiting binding of IgE to a high affinity receptor |
| 04/20/2011 | EP2311850A1 Anti-cancer cyclopenta[g]quinazoline compounds |
| 04/20/2011 | CN1835763B CCN1 compositions and methods |
| 04/07/2011 | US20110081371 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/06/2011 | EP2305298A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP2305297A1 Vaccine against streptococcus pneumoniae |
| 04/06/2011 | EP1594889B1 Nell peptide expression systems and bone formation activity of nell peptide |
| 04/05/2011 | US7919578 Methods and compositions for inhibition of BCL6 repression |
| 04/05/2011 | US7919576 Immunogenic CD19 peptides |
| 04/05/2011 | CA2402186C Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 03/30/2011 | EP2302058A1 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 03/30/2011 | EP2301960A2 Polymer conjugates of mutated neublastin |
| 03/30/2011 | EP1517710B1 Pegylated factor vii glycoforms |
| 03/23/2011 | EP2298810A2 Treatment of TNF alpha related disorders |
| 03/23/2011 | EP1666591B1 Cytokine that induces apoptosis |
| 03/10/2011 | US20110059041 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/09/2011 | EP2292763A1 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 03/02/2011 | EP2290079A2 Neurotrophic factors |
| 03/02/2011 | EP2290062A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate carboxykinase |
| 03/02/2011 | EP2289547A1 Vaccine for treatment and prevention of herpes simplex virus infection |
| 03/02/2011 | EP1766028B1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
| 03/01/2011 | US7897721 Cyclic peptide compositions for treatment of sexual dysfunction |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/22/2011 | US7893217 Isolated human antibodies that bind epitopes on RG1 |
| 02/22/2011 | US7892545 Humanized antibodies that sequester amyloid beta peptide |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/17/2011 | US20110038868 Il-17 homologous polypeptides and therapeutic uses thereof |
| 02/16/2011 | EP2284180A2 Peptides that specifically bind HGF receptor (CMET) and uses thereof |
| 02/15/2011 | US7888472 Optimized multi-epitope constructs and uses thereof |
| 02/15/2011 | US7887804 Methods for treating disease-states associated with RG1 using immunoconjugates |
| 02/15/2011 | CA2192235C Flt4 receptor tyrosine kinase and its use in diagnosis and therapy |
| 02/10/2011 | US20110033384 Chimeric polypeptides and their use |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | CN1816563B Polypeptides having binding affinity for HER2 |
| 02/03/2011 | US20110028720 New Coupling Agents for Peptide Synthesis |
| 02/01/2011 | CA2459449C Benzothiazepine and benzothiadiazepine derivatives with ileal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia |
| 01/27/2011 | US20110020396 HIV Envelope-CD4 Complexes and Hybrids |
| 01/26/2011 | EP1578778B1 Ghrelin analogs |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/25/2011 | CA2539760C Quinoline potassium channel inhibitors |
| 01/19/2011 | EP1590663B1 Immunocompromised rodents as dual color tumor models |
| 01/13/2011 | US20110008419 Vaccine Against Streptococcus Pneumoniae |
| 01/13/2011 | US20110008330 Compositions and methods of tolerizing a primate to an antigen |
| 01/12/2011 | EP2272870A1 Process for manufacturing immunoglobulins for intravenous administration and other immunoglobulin-like products |
| 01/12/2011 | CN101942018A Analogues of GLP-1 |
| 01/11/2011 | US7867704 for detecting Mycobacterium paratuberculosis in a sample using nucleic acid molecules, polypeptides, and antibodies; for immunization and prevention of mycobacterial animal infections |
| 01/05/2011 | EP2270044A1 Liquid immunoglobulin G (lgG) product |
| 01/04/2011 | US7863284 such as N-{N-{4-[N-(2-methoxymethyl-4-oxo-3,4,7,8-tetrahydro-6H-cyclo-penta[g]quinazolin-6-yl)-N-(prop-2-ynyl)amino]benzoyl}-L- gamma -glutamyl}-D-glutamic acid, used for aiding regression and palliation of ovarian cancer; antiproliferative agents |
| 12/28/2010 | US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 12/28/2010 | US7858388 modifying protein samples by combining the sample with a peroxycarbonate solution and inserting the sample into a mass spectrometer; modifying amino acids and peptides to form a t-butyl-peroxycarbamate compound; MALDI-MS; high-throughput assay |
| 12/23/2010 | US20100322954 Enhanced hiv-1 vaccines and methods for their use |
| 12/23/2010 | US20100322851 KID3 and KID3 Antibodies That Bind Thereto |
| 12/15/2010 | EP1635855B1 Selective r-cadherin antagonists and methods |
| 12/15/2010 | EP1076703B2 Therapeutic uses of il-17 homologous polypeptides |
| 12/09/2010 | US20100311189 Novel Receptor Nucleic Acids and Polypeptides |
| 12/09/2010 | US20100310510 N-terminally chemically modified protein compositions and methods |
| 12/08/2010 | EP2258848A1 Il-17 homologous polypeptide and therapeutic uses thereof |
| 12/08/2010 | EP2258381A2 Ghrelin analogs |